DURHAM, N.C. -- Antipsychotic drugs do most of their work in the brain, but they also leave behind in the bloodstream a trail of hundreds of chemicals that may be used in the future to direct better treatment for schizophrenia and other psychiatric conditions, say Duke University Medical Center researchers.The study is among the first to use metabolomics -- the measurement of thousands of chemical byproducts of the body’s cellular processes -- to look at a psychiatric disease and its response to therapy, according to the researchers.>>> Discuss This Story
